US Patent

US10966990 — Midazolam in flexible bags

Formulation · Assigned to Inforlife SA · Expires 2038-06-20 · 12y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a preservative-free aqueous midazolam solution packaged in flexible plastic containers.

USPTO Abstract

Terminally sterilized, preservative-free aqueous midazolam solution comprising 0.25 to 1.5 mg/ml of midazolam, a tonicity adjusting agent to provide an osmolality of from 260 and 320 mosm/kg and sufficient acid and optionally a base to provide a pH of from about 2.5 to 3.5 with the remainder water for injection packaged in a flexible plastic container.

Drugs covered by this patent

Patent Metadata

Patent number
US10966990
Jurisdiction
US
Classification
Formulation
Expires
2038-06-20
Drug substance claim
No
Drug product claim
Yes
Assignee
Inforlife SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.